SCHEMBL19468571

SCHEMBL19468571

COc1ccc(OC)c(C=CC(=O)c2cc(OC)c(OC)cc2CCNC(C)=O)c1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 3/20 0.70
▸ PDE4A P27815 1/20 0.59
▸ PDE4B Q07343 1/20 0.59
▸ PDE4C Q08493 1/20 0.59
▸ PDE4D Q08499 1/20 0.59
▸ ABCG2 Q9UNQ0 1/20 0.55
▸ JUN P05412 1/20 0.52
▸ NFKB1 P19838 1/20 0.52
▸ MTNR1A P48039 2/20 0.52
▸ MTNR1B P49286 2/20 0.52
▸ ATM Q13315 2/20 0.52
▸ MAPT P10636 3/20 0.50
▸ KDM4E B2RXH2 2/20 0.50
▸ L3MBTL1 Q9Y468 2/20 0.50
▸ APP P05067 1/20 0.50
▸ LMNA P02545 1/20 0.50
▸ ALDH1A1 P00352 1/20 0.49
▸ POLB P06746 1/20 0.49
▸ GAA P10253 1/20 0.49
▸ HPGD P15428 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19468569 1.00 SMN1; SMN2 (0.70) SMN1; SMN2PDE4APDE4BPDE4CPDE4D
SCHEMBL19468574 0.92 SMN1; SMN2 (0.70) SMN1; SMN2PDE4APDE4BPDE4CPDE4D
SCHEMBL19468578 0.87 SMN1; SMN2 (0.82) SMN1; SMN2MTNR1AMTNR1BMAPTKDM4E
SCHEMBL19468566 0.84 SMN1; SMN2 (0.68) SMN1; SMN2PDE4APDE4BPDE4CPDE4D
SCHEMBL19468576 0.84 SMN1; SMN2 (0.67) SMN1; SMN2PDE4APDE4BPDE4CPDE4D
SCHEMBL19468570 0.82 SMN1; SMN2 (1.00) SMN1; SMN2MTNR1AMTNR1BMAPTKDM4E
SCHEMBL7194877 0.76 PDE4A (0.81) SMN1; SMN2PDE4APDE4BPDE4CPDE4D
SCHEMBL18183442 0.76 MTNR1B (0.84) MTNR1AMTNR1B
SCHEMBL7194872 0.76 PDE4A (0.81) SMN1; SMN2PDE4APDE4BPDE4CPDE4D
SCHEMBL31467939 0.75 SMN1; SMN2 (0.54) SMN1; SMN2ABCG2MTNR1AMTNR1BMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3278797-A1 ANTIALLERGIC AGENT Tohoku University (JP) 2018-02-07 — — EP disclosed
US-20170304236-A1 ANTIALLERGIC AGENT TOHOKU UNIVERSITY (JP) 2017-10-26 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170304236-A1 ANTIALLERGIC AGENT HRH2, HRH4, HRH1 SMN1; SMN2 3336/4885PDE4A 845/4885PDE4B 1003/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback